| An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer (NCT00207155) | Eli Lilly and Company | 2003-12-01 |
| Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes (NCT01615978) | Novo Nordisk A/S | 2003-12-01 |
| Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin (NCT00111982) | Amgen | 2003-12-01 |
| Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg (NCT00649714) | Mylan Pharmaceuticals Inc | 2003-12-01 |
| Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients (NCT00228189) | Radboud University Medical Center | 2003-12-01 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects (NCT01527656) | Novo Nordisk A/S | 2003-12-01 |
| Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients (NCT00818597) | University of Rostock | 2003-12-01 |
| Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers (NCT02259920) | Boehringer Ingelheim | 2003-12-01 |
| Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT00081133) | Memorial Sloan Kettering Cancer Center | 2003-12-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects (NCT02944474) | Idorsia Pharmaceuticals Ltd. | 2003-12-01 |
| Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) (NCT00074750) | M.D. Anderson Cancer Center | 2003-12-01 |
| Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer (NCT00316420) | Swedish Medical Center | 2003-12-01 |
| Zalutumumab in Head and Neck Cancer (NCT00093041) | Genmab | 2003-12-01 |
| Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors (NCT00098514) | Dana-Farber Cancer Institute | 2003-12-01 |
| RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) (NCT00157027) | Atlantic Health System | 2003-12-01 |
| Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer (NCT00084591) | Fox Chase Cancer Center | 2003-12-01 |
| Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer (NCT00132756) | Morton Plant Mease Health Care | 2003-12-01 |
| The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects (NCT00865267) | Actavis Inc. | 2003-12-01 |
| Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer (NCT00073723) | Celgene Corporation | 2003-12-01 |
| Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults (NCT00071851) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-12-01 |
| Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00080665) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2003-12-01 |
| Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00088959) | National Cancer Institute (NCI) | 2003-12-01 |
| Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas (NCT00074646) | Celgene Corporation | 2003-12-01 |
| Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg (NCT00648518) | Mylan Pharmaceuticals Inc | 2003-12-01 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects (NCT01620437) | Novo Nordisk A/S | 2003-11-29 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects (NCT01527643) | Novo Nordisk A/S | 2003-11-11 |
| Improvement of Use Dependent Plasticity in Chronic Stroke Patients (NCT00072735) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-11-06 |
| Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease (NCT00072826) | National Institutes of Health Clinical Center (CC) | 2003-11-04 |
| Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer (NCT00066443) | NCIC Clinical Trials Group | 2003-11-03 |
| Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults (NCT00192465) | MedImmune LLC | 2003-11-01 |
| Cilostazol 100 mg Tablet Formulations Under Fasting Conditions (NCT00838630) | Teva Pharmaceuticals USA | 2003-11-01 |
| Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support (NCT00506857) | M.D. Anderson Cancer Center | 2003-11-01 |
| Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors (NCT00074321) | National Cancer Institute (NCI) | 2003-11-01 |
| Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children (NCT00076999) | Boehringer Ingelheim | 2003-11-01 |
| Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions (NCT00836056) | Teva Pharmaceuticals USA | 2003-11-01 |
| Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (NCT00121173) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2003-11-01 |
| Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer (NCT00795977) | Fukushima Medical University | 2003-11-01 |
| Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies (NCT00243295) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-11-01 |
| A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED) (NCT00971633) | Merck Sharp & Dohme LLC | 2003-11-01 |
| Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer (NCT01644968) | Providence Health & Services | 2003-11-01 |
| Distance Healing in Wound Healing (NCT00067717) | California Pacific Medical Center Research Institute | 2003-11-01 |
| Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma (NCT00670410) | Columbia University | 2003-11-01 |
| Study Evaluating HKI-272 in Tumors (NCT00146172) | Puma Biotechnology, Inc. | 2003-11-01 |
| Electromagnetic Treatment For Bone Loss After Forearm Fracture (NCT00067834) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2003-11-01 |
| Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults (NCT00078559) | University of Wisconsin, Madison | 2003-11-01 |
| Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00310154) | Wake Forest University Health Sciences | 2003-11-01 |
| Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer (NCT00084526) | Fox Chase Cancer Center | 2003-11-01 |
| Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions (NCT00803946) | Perrigo Company | 2003-11-01 |
| Barriers to Treatment in Obese Adolescents (NCT00167830) | Virginia Commonwealth University | 2003-11-01 |
| BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia (NCT00103701) | Bristol-Myers Squibb | 2003-11-01 |
| IdB 1016 Treatment for Hepatitis C Disease (NCT00055445) | National Center for Complementary and Integrative Health (NCCIH) | 2003-11-01 |
| Fasting Study of Mercaptopurine 50 mg and Purinethol® Tablets 50 mg (NCT00648336) | Mylan Pharmaceuticals Inc | 2003-11-01 |
| Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg (NCT00650052) | Mylan Pharmaceuticals Inc | 2003-11-01 |
| Comparison of CXR and MnDCT (NCT00188435) | University Health Network, Toronto | 2003-11-01 |
| Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration (NCT00987376) | Mayo Clinic | 2003-11-01 |
| Stem Cell Study for Patients With Leg Ulcer/Gangrene (NCT00221143) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2003-11-01 |
| Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix (NCT00084890) | Wake Forest University Health Sciences | 2003-11-01 |
| Combination Paclitaxel, Carboplatin and Temozolomide (NCT00249964) | New Mexico Cancer Research Alliance | 2003-11-01 |
| Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171637) | Boehringer Ingelheim | 2003-11-01 |
| Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer (NCT00072410) | Ludwig Institute for Cancer Research | 2003-11-01 |
| Effects of Smoked Marijuana on Neuropathic Pain (NCT00254761) | Center for Medicinal Cannabis Research | 2003-11-01 |
| E. Coli for Prevention of Catheter UTI in SCI Patients (NCT00458471) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2003-11-01 |
| Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides (NCT00400101) | Swiss Tropical & Public Health Institute | 2003-11-01 |
| Vaccine Therapy in Treating Patients With Kidney Cancer (NCT00096629) | Memorial Sloan Kettering Cancer Center | 2003-11-01 |
| MD Ezetimibe Cyclosporine Interaction (0653-057) (NCT00653276) | Organon and Co | 2003-11-01 |
| Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia (NCT00634881) | German CLL Study Group | 2003-11-01 |
| BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate (NCT00064233) | Jonsson Comprehensive Cancer Center | 2003-11-01 |
| A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 (NCT00212108) | National University Hospital, Singapore | 2003-11-01 |
| Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis (NCT00633191) | Immunsystem AB | 2003-11-01 |
| A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT00819754) | Ottawa Hospital Research Institute | 2003-11-01 |
| Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia (NCT00078234) | Genta Incorporated | 2003-11-01 |
| Food Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg (NCT00647985) | Mylan Pharmaceuticals Inc | 2003-11-01 |
| Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions (NCT00659685) | Par Pharmaceutical, Inc. | 2003-11-01 |
| Vaccine Treatment for Advanced Non-Small Cell Lung Cancer (NCT00073398) | NewLink Genetics Corporation | 2003-11-01 |
| Dose-Escalation Study in Advanced Colon Cancer Patients (NCT00969046) | Novartis Pharmaceuticals | 2003-11-01 |
| Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 Diabetes (NCT00141986) | Canadian Diabetes Association | 2003-11-01 |
| Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer (NCT00075673) | Case Comprehensive Cancer Center | 2003-11-01 |
| Clindamycin 300 mg Capsules in Healthy Subjects Under Fed Conditions (NCT00836004) | Teva Pharmaceuticals USA | 2003-11-01 |
| Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer (NCT00077103) | Case Comprehensive Cancer Center | 2003-11-01 |
| Experimental Ebola Vaccine Trial (NCT00072605) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-30 |
| Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL (NCT00089284) | Northwestern University | 2003-10-28 |
| Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas (NCT00070070) | Ludwig Institute for Cancer Research | 2003-10-28 |
| A Clinical Study in Healthy Women Which Aims to Explore the Intestinal Uptake of Two Different Tablets of GRTA9906 Into the Body and the Effect of Food on it (NCT03765801) | Grünenthal GmbH | 2003-10-22 |
| Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF) (NCT00809588) | Dana-Farber Cancer Institute | 2003-10-16 |
| Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders (NCT00071227) | National Eye Institute (NEI) | 2003-10-15 |
| Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects (NCT02251158) | Boehringer Ingelheim | 2003-10-01 |
| New Pharmacological Treatment for Obstructive Sleep Apnea (NCT00108498) | US Department of Veterans Affairs | 2003-10-01 |
| Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State (NCT00647738) | Mylan Pharmaceuticals Inc | 2003-10-01 |
| An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies (NCT00072592) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults (NCT01767402) | GlaxoSmithKline | 2003-10-01 |
| Tolerance and Pharmacokinetics Study of MNTX Tablets (NCT01366339) | Bausch Health Americas, Inc. | 2003-10-01 |
| Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability (NCT00242177) | University of Illinois at Chicago | 2003-10-01 |
| Role of Pioglitazone in Preventing Diabetes (NCT00276497) | M.V. Hospital for Diabetes | 2003-10-01 |
| Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer (NCT00068549) | Gynecologic Oncology Group | 2003-10-01 |
| Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis (NCT00709722) | Nippon Kayaku Co., Ltd. | 2003-10-01 |
| AMP as a Better Delivery System of Adenosine (NCT00179010) | Vanderbilt University Medical Center | 2003-10-01 |
| Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries (NCT00867867) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2003-10-01 |
| Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection (NCT02799498) | Amgen | 2003-10-01 |
| Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. (NCT00209690) | Hokkaido Gastrointestinal Cancer Study Group | 2003-10-01 |
| Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers (NCT01679002) | Bial - Portela C S.A. | 2003-10-01 |